This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A Controlled Trial

Samuel G. Siris, MD; Victoria Morgan; Richard Fagerstrom, PhD; Arthur Rifkin, MD; Thomas B. Cooper, MA

Arch Gen Psychiatry. 1987;44(6):533-539.

Abstract
• The efficacy of adjunctive imipramine hydrochloride treatment for syndromally defined postpsychotic depression was assessed in a six-week, double-blind, placebo-controlled study. All patients had been diagnosed as having schizophrenia or schizoaffective disorder, all were receiving stable doses of fluphenazine decanoate, and all had received benztropine mesylate in an attempt to rule out neuroleptic-induced akinesia. Patients randomized to imipramine therapy fared significantly better in terms of their global improvement and in terms of individual symptoms that are components of the depression syndrome. There were no significant differences in outcome psychosis ratings or side effects. This study indicates the existence of an identifiable syndrome of secondary depression in this patient group that is likely to respond favorably to treatment with adjunctive imipramine.

Author Affiliations
From the Departments of Psychiatry (Drs Siris and Rifkin and Ms Morgan) and Biostatistics (Dr Fagerstrom), Mount Sinai School of Medicine, City University of New York; and the Nathan Kline Research Institute, Orangeburg, NY, and New York State Psychiatric Institute, New York (Mr Cooper).

Footnotes
Accepted for publication April 10, 1986.

Reprint requests to Mount Sinai Medical Center, KCC 1 South, One Gustave L. Levy Place, New York, NY 10029 (Dr Siris).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Psychiatric Comorbidities and Schizophrenia
Buckley et al.
Schizophr Bull 2009;35:383-402.
ABSTRACT | FULL TEXT  

Baseline Use of Concomitant Psychotropic Medications to Treat Schizophrenia in the CATIE Trial
Chakos et al.
Psychiatr. Serv. 2006;57:1094-1101.
ABSTRACT | FULL TEXT  

Treating Depression in Schizophrenia
LUND et al.
Am. J. Psychiatry 2001;158:1528-1528.
FULL TEXT  

Diagnosis and Treatment of Mood Disorders That Co-occur With Schizophrenia
Escamilla
Psychiatr. Serv. 2001;52:911-919.
ABSTRACT | FULL TEXT  

Suicide and schizophrenia
Siris
J Psychopharmacol 2001;15:127-135.
ABSTRACT  

Depression in Schizophrenia: Perspective in the Era of "Atypical" Antipsychotic Agents
Siris
Am. J. Psychiatry 2000;157:1379-1389.
ABSTRACT | FULL TEXT  

Treatment of Schizoaffective Disorder and Schizophrenia With Mood Symptoms
Levinson et al.
Am. J. Psychiatry 1999;156:1138-1148.
ABSTRACT | FULL TEXT  

Depressive Signs and Symptoms in Schizophrenia: A Prospective Blinded Trial of Olanzapine and Haloperidol
Tollefson et al.
Arch Gen Psychiatry 1998;55:250-258.
ABSTRACT | FULL TEXT  

Schizophrenia
Kane
NEJM 1996;334:34-42.
FULL TEXT  

The drug treatment of patients with schizophrenia
DTB 1995;33:81-86.
ABSTRACT | FULL TEXT  

Pharmacotherapy of Impaired Affect in Recovering Schizophrenic Patients
Hogarty et al.
Arch Gen Psychiatry 1995;52:29-41.
ABSTRACT  

Schizophrenia
Carpenter and Buchanan
NEJM 1994;330:681-690.
FULL TEXT  

Maintenance Imipramine Therapy for Secondary Depression in Schizophrenia: A Controlled Trial
Siris et al.
Arch Gen Psychiatry 1994;51:109-115.
ABSTRACT  

Progress in Psychiatry- First of Two Parts
Michels and Marzuk
NEJM 1993;329:552-560.
FULL TEXT  

Depressive Symptoms as Relative and Attributable Risk Factors for First-Onset Major Depression
Horwath et al.
Arch Gen Psychiatry 1992;49:817-823.
ABSTRACT  

Antidepressants in 'Depressed' Schizophrenic Inpatients: A Controlled Trial
Kramer et al.
Arch Gen Psychiatry 1989;46:922-928.
ABSTRACT  

Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
Siris
Arch Gen Psychiatry 1988;45:1055-1055.
ABSTRACT